Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma

HIGHLIGHTS

• who: Yaron Rudman and collaborators from the (UNIVERSITY) have published the article: Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma, in the Journal: (JOURNAL)
• what: The aims of treatment in male macroprolactinoma include prolactin normalization, tumor mass reduction and gonadal axis recovery . The aim of this study was to identify the baseline characteristics predicting long-term HH persistence in a large cohort of male macroprolactinoma, that achieved normoprolactinemia following medical treatment with cabergoline. Noteworthy, in this study design, there is an inherent selection bias because patients with a more benign presentation must be excluded (group A . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.